Impact of Secukinumab on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis in a Randomized Phase 3 Trial

Strand V., Kaeley GS., Bergman MJ., Gladman DD., COATES LC., Sherif B., Hur P., Parikh B., Gilloteau I., Mease PJ.

Type

Journal article

Journal

Lancet rheumatology

Publication Date

02/12/2021

Permalink